Io Therapeutics, Inc. — Form D

Io Therapeutics, Inc. of SPRING, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-09. The offering totals $4.2M, of which $4.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-03-09
• Form: D
• Accession: 0001538762-23-000003
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $4.2M
• Amount sold: $4.2M
• Investors: 19
• Date of first sale: 2023-02-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-475300

Issuer

• Name: Io Therapeutics, Inc.
• CIK: 0001538762
• Entity type: Corporation
• Jurisdiction: TEXAS
• Incorporated: 2010
• Address: 9450 PINECROFT DR., SUITE 9497, SPRING, TX, 77387
• Phone: 832-260-6201

Officers, directors & promoters (9)

Other filings by this issuer (2)

More

• CIK 1538762 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search